メニュー 戻るLS02 Quality Control in the E6(R3) Era: What Should the Quality-Control Process Emphasize?

19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

価格は消費税抜きとなっております。

LS02 Quality Control in the E6(R3) Era: What Should the Quality-Control Process Emphasize?

Session Chair(s)

Katsuhiko Sawada, MPharm

Katsuhiko Sawada, MPharm

  • Director, Research and Development Dept.
  • Otsuka Medical Devices Co.Ltd., Japan

Speaker(s)

Satoko Sakai

Satoko Sakai

  • Manager of Clinical Quality Management
  • Idorsia Pharmaceuticals Japan Ltd., Japan
TOMONORI ABE

TOMONORI ABE

  • Associate Manager
  • Linical Co., Ltd., Japan
Yuko Kageyama, MT

Yuko Kageyama, MT

  • Clinical Research Promotion Center P1 Unit
  • The University of Tokyo Hospital, Japan